
304.50 Delayed Data As of Dec 04 | ![]() Today’s Change | 262.50 Today|||52-Week Range 410.00 | -21.82% Year-to-Date |
Small-Cap Russell Leads the Way, Jobs Data to Come Dec 04 / Zacks.com - Paid Partner Content | Regeneron (REGN), Sanofi's Dupixent Succeeds in 2nd COPD Study Nov 27 / Zacks.com - Paid Partner Content |
Roche (RHHBY) to Acquire Obesity Drug Maker Carmot for $2.7B Dec 04 / Zacks.com - Paid Partner Content | Regeneron (REGN) Stock Rallies 10% YTD: What Lies Ahead? Nov 24 / Zacks.com - Paid Partner Content |
Novartis (NVS) Raises Mid-Term Sales Outlook; Outlines Strategy Nov 28 / Zacks.com - Paid Partner Content | Ignore Crypto: These Stocks Could Make You Rich Nov 23 / MotleyFool.com - Paid Partner Content |
Previous close | 291.00 |
Today’s open | 294.00 |
Day’s range | 294.00 - 306.50 |
Volume | 116 |
Average volume (3 months) | 87 |
Market cap | $31.0B |
Earnings growth (last year) | -9.31% |
Earnings growth (this year) | -- |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | -3.54% |
P/E ratio | -- |
Price/Sales | 4.68 |
Price/Book | 7.69 |
No competitors data available. |
Next reporting date | -- |
EPS forecast (this quarter) | -- |
Annual revenue (last year) | $66.3B |
Annual profit (last year) | $13.0B |
Net profit margin | 19.63% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Basel, Basel-stadt (basle Town) |